Roche Confirms 2020 Outlook Despite Decrease in Sales
October 15 2020 - 2:11AM
Dow Jones News
By Cecilia Butini
Roche Holding AG said Thursday that sales in the period from
January to September fell on year, but it backed its outlook for
2020.
Sales at the Swiss pharmaceutical major were 43.98 billion Swiss
francs ($48.15 billion) for the period, down from CHF46.07 billion
in the same period last year, the company said.
The diagnostics division boosted company sales, particularly in
the third quarter, driven by PCR tests for Covid-19.
The company expects sales to grow in the low-to-mid-single digit
range in 2020, it said, confirming its previous outlook.
Roche also said that it plans to further increase its dividend
in 2020.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
October 15, 2020 01:56 ET (05:56 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
